These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 7494781)
21. Potentiation by a progrestational agent of liver damage induced by a hepatotoxic agent. Joshi UM; Rao SS Indian J Exp Biol; 1969 Apr; 7(2):79-81. PubMed ID: 5798615 [No Abstract] [Full Text] [Related]
22. There are many benzo-pyrones for lymphedema. Casley-Smith JR Lymphology; 1997 Mar; 30(1):38-9. PubMed ID: 9106139 [No Abstract] [Full Text] [Related]
23. Protective effects of coumarin and coumarin derivatives against carbon tetrachloride-induced acute hepatotoxicity in rats. Murat Bilgin H; Atmaca M; Deniz Obay B; Ozekinci S; Taşdemir E; Ketani A Exp Toxicol Pathol; 2011 May; 63(4):325-30. PubMed ID: 20207117 [TBL] [Abstract][Full Text] [Related]
24. Frequency of coumarin hepatotoxicity. Casley-Smith JR; Casley-Smith JR Med J Aust; 1995 Apr; 162(7):391. PubMed ID: 7715532 [No Abstract] [Full Text] [Related]
25. [Acute liver cell degeneration with hepatorenal syndrome in monocoumarolin intoxication]. Stark U; Zalaudek G; Samec H; Sterz H Wien Med Wochenschr; 1971 Apr; 121(17):358-61. PubMed ID: 5575103 [No Abstract] [Full Text] [Related]
26. [The liver disease in the toxic oil syndrome. Development after a year follow-up]. Mearin F; Moreno Otero R; Rodríguez S; Del Pozo A; García-Méndez JA; Pájares JM Rev Esp Enferm Apar Dig; 1983 Jan; 63(1):76-82. PubMed ID: 6135243 [No Abstract] [Full Text] [Related]
27. Coumarin-Induced Hepatotoxicity: A Narrative Review. Pitaro M; Croce N; Gallo V; Arienzo A; Salvatore G; Antonini G Molecules; 2022 Dec; 27(24):. PubMed ID: 36558195 [TBL] [Abstract][Full Text] [Related]
29. Treatment of lymphedema of the arms and legs with 5,6-benzo-[alpha]-pyrone. Casley-Smith JR; Morgan RG; Piller NB N Engl J Med; 1993 Oct; 329(16):1158-63. PubMed ID: 8377779 [TBL] [Abstract][Full Text] [Related]
30. [Behavior of gamma glutamyl transpeptidase in hepatobiliary diseases]. Kresbach E; Thurnher H Wien Med Wochenschr; 1973 Apr; 123(16):253-8. PubMed ID: 4144931 [No Abstract] [Full Text] [Related]
36. Diurnal variation of serum alanine transaminase activity in chronic liver disease. Córdoba J; O'Riordan K; Dupuis J; Borensztajin J; Blei AT Hepatology; 1998 Dec; 28(6):1724-5. PubMed ID: 9890798 [No Abstract] [Full Text] [Related]
37. [Morphological and functional changes in the liver after intravenous injections of glucose and fructose in the rat]. Orcel L; Giboudeau J; Roland J Pathol Eur; 1970; 5(4):377-83. PubMed ID: 5515045 [No Abstract] [Full Text] [Related]